Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEF0217 in Adults and Older Adolescents With Down Syndrome
NCT07334912Phase 2Recruiting
- Sponsor
- Aelis Farma
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of AEF0217 in Down syndrome, sponsored by Aelis Farma. Started Dec 2025; status: recruiting.
02
Drugs
AEF0217
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT07334912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07334912.